We are monitoring the impact of COVID-19 & Recession alarm on Eastern Europe Biopharmaceuticals Market Get in touch with us for detailed analysis Know More

Know More

Share on

Eastern Europe Biopharmaceuticals Market Report - By Product Type, Therapeutic Type and Country - Industry Analysis, Size, Share, Growth, Trends and Forecasts (2022 to 2027)

Published: January, 2022
ID: 7502
Pages: 180

The Eastern Europe Biopharmaceuticals market is estimated to grow at a steady growth rate during the forecast period. 

Development of biopharmaceutical product is being undertaken by increasing the number of competitors in the pharmaceutical industry. Market players are more focusing on expanding the biologics pipeline, relying on the fact that commercialization of biopharmaceuticals will reduce the usage of traditional small molecular drugs. Pharmaceutical industries mainly rely on biopharmaceuticals for profits and innovation.

Advancement in biomedical science holds vast potential for the growth of the biopharmaceuticals market. The ability of these drugs to treat chronic diseases which were earlier untreatable is increasing its demand enormously and also increases the profit margin for manufacturers. Biopharmaceutical drugs need to be stored in cold storage which limits their transport to rural areas and hence hindering the growth of the market.

The Eastern Europe biopharmaceuticals market is segmented based on products into Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte colony-stimulating factor (G-CSF), Interferon and Human growth hormones (HGH). Monoclonal antibodies segment holds the highest number of shares in the product sector. Based on therapeutics, the market is bifurcated into Neurology, Infectious diseases, Diabetes, Oncology, Cardiovascular and other therapeutic areas. In terms of therapeutic application, oncology is the largest segment in the biopharmaceuticals market.

Based on geography, the market is analyzed under various countries, namely, Ukraine, Poland, Romania, Czech Republic, Hungary and Rest of Eastern Europe.

Merck & Co., Inc., F. Hoffmann-La Roche AG, Eli Lilly and Company, Inc., Sanofi, Amgen Inc., AbbVie Inc., Biogen Idec, Bayer AG, Johnson & Johnson Services, Pfizer, Inc., and Novartis AG are some of the leading players in the market for biopharmaceuticals.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 Ukraine

                                6.3 Poland           

                                6.4 Romania     

                                6.5 Czech Republic               

                                6.6 Hungary

                                6.7 Rest of Eastern Europe

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Eastern Europe Biopharmaceuticals Market By Region, From 2022 - 2027 (USD Billion)
  2. Eastern Europe Biopharmaceuticals Market By Product Type, From 2022 - 2027 (USD Billion)
  3. Eastern Europe Monoclonal Antibodies (mAb) Market By Region, From 2022 - 2027 (USD Billion)
  4. Eastern Europe Erythropoietin Market By Region, From 2022 - 2027 (USD Billion)
  5. Eastern Europe Biotech Vaccines Market By Region, From 2022 - 2027 (USD Billion)
  6. Eastern Europe Recombinant Human (RH) Insulin Market By Region, From 2022 - 2027 (USD Billion)
  7. Eastern Europe Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2022 - 2027 (USD Billion)
  8. Eastern Europe Interferon Market By Region, From 2022 - 2027 (USD Billion)
  9. Eastern Europe Human growth hormones (HGH) Market By Region, From 2022 - 2027 (USD Billion)
  10. Eastern Europe Biopharmaceuticals Market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  11. Eastern Europe Neurology Market By Region, From 2022 - 2027 (USD Billion)
  12. Eastern Europe Infectious diseases Market By Region, From 2022 - 2027 (USD Billion)
  13. Eastern Europe Diabetes Market By Region, From 2022 - 2027 (USD Billion)
  14. Eastern Europe Oncology Market By Region, From 2022 - 2027 (USD Billion)
  15. Eastern Europe Cardiovascular Market By Region, From 2022 - 2027 (USD Billion)
  16. Eastern Europe Other Therapeutic Areas Market By Region, From 2022 - 2027 (USD Billion)
  17. Ukraine Biopharmaceuticals Market By Product Type, From 2022 - 2027 (USD Billion)
  18. Ukraine Biopharmaceuticals Market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  19. Poland Biopharmaceuticals Market By Product Type, From 2022 - 2027 (USD Billion)
  20. Poland Biopharmaceuticals Market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  21. Hungary Biopharmaceuticals Market By Product Type, From 2022 - 2027 (USD Billion)
  22. Hungary Biopharmaceuticals Market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  23. Romania Biopharmaceuticals Market By Product Type, From 2022 - 2027 (USD Billion)
  24. Romania Biopharmaceuticals Market By Therapeutic Type, From 2022 - 2027 (USD Billion)
  25. Czech Republic Biopharmaceuticals Market By Product Type, From 2022 - 2027 (USD Billion)
  26. Czech Republic Biopharmaceuticals Market By Therapeutic Type, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

PURCHASE OPTIONS

pdf
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample